• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country.

作者信息

Senapati Jayastu, Dhawan Rishi, Aggarwal Mukul, Kumar Pradeep, Kumar Vishwanathan Ganesh, Dass Jasmita, Tyagi Seema, Mahapatra Manoranjan, Seth Tulika

机构信息

Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Leuk Lymphoma. 2021 Jun;62(6):1514-1517. doi: 10.1080/10428194.2020.1867724. Epub 2021 Jan 15.

DOI:10.1080/10428194.2020.1867724
PMID:33448885
Abstract
摘要

相似文献

1
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country.维奈托克与阿扎胞苷（VenAZA）联合疗法用于年轻、身体状况不佳的急性髓系白血病患者：来自一个发展中国家的观点
Leuk Lymphoma. 2021 Jun;62(6):1514-1517. doi: 10.1080/10428194.2020.1867724. Epub 2021 Jan 15.
2
Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia.阿扎胞苷和维奈托克治疗不适合治疗的初治急性髓系白血病患者的成本效益。
Blood Adv. 2021 Feb 23;5(4):994-1002. doi: 10.1182/bloodadvances.2020003902.
3
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia.伴有阿扎胞苷的维奈托克治疗未经治疗的急性髓系白血病患者的真实世界经验。
Blood Adv. 2019 Oct 22;3(20):2911-2919. doi: 10.1182/bloodadvances.2019000243.
4
Venetoclax in AML: efficacy confirmed.维奈托克治疗急性髓系白血病：疗效得到证实。
Nat Rev Clin Oncol. 2020 Oct;17(10):592. doi: 10.1038/s41571-020-00430-8.
5
Azacitidine and Venetoclax in AML.阿扎胞苷与维奈克拉治疗急性髓系白血病
N Engl J Med. 2020 Nov 19;383(21):2087. doi: 10.1056/NEJMc2029153.
6
Azacitidine and Venetoclax in AML.阿扎胞苷与维奈克拉治疗急性髓系白血病
N Engl J Med. 2020 Nov 19;383(21):2087-2088. doi: 10.1056/NEJMc2029153.
7
Azacitidine and Venetoclax in AML.阿扎胞苷与维奈克拉治疗急性髓系白血病
N Engl J Med. 2020 Nov 19;383(21):2088. doi: 10.1056/NEJMc2029153.
8
Azacitidine and Venetoclax in AML. Reply.阿扎胞苷与维奈克拉治疗急性髓系白血病。回复。
N Engl J Med. 2020 Nov 19;383(21):2088-2089. doi: 10.1056/NEJMc2029153.
9
Venetoclax with decitabine or azacitidine for AML.维奈托克联合地西他滨或阿扎胞苷治疗急性髓系白血病
Lancet Oncol. 2018 Dec;19(12):e672. doi: 10.1016/S1470-2045(18)30824-6. Epub 2018 Nov 1.
10
Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia.单中心儿科应用维奈托克联合阿扎胞苷治疗骨髓增生异常综合征和急性髓系白血病的经验。
Pediatr Blood Cancer. 2020 Oct;67(10):e28398. doi: 10.1002/pbc.28398. Epub 2020 Jul 31.

引用本文的文献

1
Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities.维奈托克联合去甲基化药物用于急性髓系白血病诱导治疗的疗效及预后分析：一项关于适应证特异性分层、分子标志物和血液学毒性的多中心真实世界研究
Cancer Cell Int. 2025 Jul 1;25(1):241. doi: 10.1186/s12935-025-03858-z.
2
Azacytidine and Venetoclax as a Salvage Therapy for Relapsed/Refractory Acute Myeloid Leukemia: A Single Centre Experience.阿扎胞苷和维奈克拉作为复发/难治性急性髓系白血病挽救治疗的单中心经验
Indian J Hematol Blood Transfus. 2025 Jan;41(1):197-199. doi: 10.1007/s12288-024-01802-1. Epub 2024 Jun 18.
3
Clinical Outcomes and Determinants of Survival in Patients with Hematologic Malignancies Admitted to Intensive Care Units with Critical Illness.入住重症监护病房的重症血液系统恶性肿瘤患者的临床结局及生存决定因素
Indian J Hematol Blood Transfus. 2024 Jul;40(3):423-431. doi: 10.1007/s12288-024-01757-3. Epub 2024 Mar 25.
4
[Retrospective analysis of the efficacy and safety of Venetoclax-based regimen in the treatment of 12 cases of acute myeloid leukemia with t (8; 21)].[维奈克拉方案治疗12例伴t(8;21)急性髓系白血病疗效及安全性的回顾性分析]
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):501-504. doi: 10.3760/cma.j.issn.0253-2727.2023.06.011.
5
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience.维奈托克用于儿童急性髓系白血病：德克萨斯医学中心的经验
Cancers (Basel). 2023 Mar 26;15(7):1983. doi: 10.3390/cancers15071983.
6
[Short-term efficacy of venetoclax combined with azacitidine in acute myeloid leukemia: a single-institution experience].维奈托克联合阿扎胞苷治疗急性髓系白血病的短期疗效：单机构经验
Zhonghua Xue Ye Xue Za Zhi. 2022 Feb 14;43(2):134-140. doi: 10.3760/cma.j.issn.0253-2727.2022.02.008.